NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 132 filers reported holding NOVAVAX INC in Q4 2013. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $35,000 | +3400.0% | 63,667 | +21336.7% | 0.00% | – |
Q4 2018 | $1,000 | -96.4% | 297 | -98.0% | 0.00% | -100.0% |
Q3 2018 | $28,000 | +21.7% | 14,898 | -14.2% | 0.00% | +100.0% |
Q2 2018 | $23,000 | +53.3% | 17,362 | +148.7% | 0.00% | 0.0% |
Q1 2018 | $15,000 | -6.2% | 6,981 | -45.9% | 0.00% | -50.0% |
Q4 2017 | $16,000 | +700.0% | 12,914 | +659.6% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 1,700 | +240.0% | 0.00% | – |
Q4 2016 | $1,000 | -87.5% | 500 | -66.1% | 0.00% | -100.0% |
Q1 2016 | $8,000 | +166.7% | 1,473 | +223.0% | 0.00% | – |
Q3 2015 | $3,000 | -95.5% | 456 | -92.3% | 0.00% | -100.0% |
Q2 2015 | $66,000 | -54.2% | 5,924 | -65.9% | 0.01% | -66.7% |
Q1 2015 | $144,000 | +1957.1% | 17,383 | +1480.3% | 0.02% | +1700.0% |
Q4 2014 | $7,000 | -89.6% | 1,100 | -93.1% | 0.00% | -87.5% |
Q3 2014 | $67,000 | +1575.0% | 16,051 | +1906.4% | 0.01% | +700.0% |
Q2 2014 | $4,000 | -71.4% | 800 | -74.2% | 0.00% | -50.0% |
Q1 2014 | $14,000 | -92.2% | 3,100 | -94.6% | 0.00% | -89.5% |
Q3 2013 | $180,000 | – | 57,289 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |